pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-449b |
Genomic Coordinates | chr5: 55170646 - 55170742 |
Description | Homo sapiens miR-449b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-449b-5p | ||||||||||||||||||
Sequence | 16| AGGCAGUGUAUUGUUAGCUGGC |37 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Microarray | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TGFBR2 | ||||||||||||||||||||
Synonyms | AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII | ||||||||||||||||||||
Description | transforming growth factor beta receptor 2 | ||||||||||||||||||||
Transcript | NM_001024847 | ||||||||||||||||||||
Other Transcripts | NM_003242 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TGFBR2 | |||||||||||||||||||||
3'UTR of TGFBR2 (miRNA target sites are highlighted) |
>TGFBR2|NM_001024847|3'UTR 1 CTCTTCTGGGGCAGGCTGGGCCATGTCCAAAGAGGCTGCCCCTCTCACCAAAGAACAGAGGCAGCAGGAAGCTGCCCCTG 81 AACTGATGCTTCCTGGAAAACCAAGGGGGTCACTCCCCTCCCTGTAAGCTGTGGGGATAAGCAGAAACAACAGCAGCAGG 161 GAGTGGGTGACATAGAGCATTCTATGCCTTTGACATTGTCATAGGATAAGCTGTGTTAGCACTTCCTCAGGAAATGAGAT 241 TGATTTTTACAATAGCCAATAACATTTGCACTTTATTAATGCCTGTATATAAATATGAATAGCTATGTTTTATATATATA 321 TATATATATCTATATATGTCTATAGCTCTATATATATAGCCATACCTTGAAAAGAGACAAGGAAAAACATCAAATATTCC 401 CAGGAAATTGGTTTTATTGGAGAACTCCAGAACCAAGCAGAGAAGGAAGGGACCCATGACAGCATTAGCATTTGACAATC 481 ACACATGCAGTGGTTCTCTGACTGTAAAACAGTGAACTTTGCATGAGGAAAGAGGCTCCATGTCTCACAGCCAGCTATGA 561 CCACATTGCACTTGCTTTTGCAAAATAATCATTCCCTGCCTAGCACTTCTCTTCTGGCCATGGAACTAAGTACAGTGGCA 641 CTGTTTGAGGACCAGTGTTCCCGGGGTTCCTGTGTGCCCTTATTTCTCCTGGACTTTTCATTTAAGCTCCAAGCCCCAAA 721 TCTGGGGGGCTAGTTTAGAAACTCTCCCTCAACCTAGTTTAGAAACTCTACCCCATCTTTAATACCTTGAATGTTTTGAA 801 CCCCACTTTTTACCTTCATGGGTTGCAGAAAAATCAGAACAGATGTCCCCATCCATGCGATTGCCCCACCATCTACTAAT 881 GAAAAATTGTTCTTTTTTTCATCTTTCCCCTGCACTTATGTTACTATTCTCTGCTCCCAGCCTTCATCCTTTTCTAAAAA 961 GGAGCAAATTCTCACTCTAGGCTTTATCGTGTTTACTTTTTCATTACACTTGACTTGATTTTCTAGTTTTCTATACAAAC 1041 ACCAATGGGTTCCATCTTTCTGGGCTCCTGATTGCTCAAGCACAGTTTGGCCTGATGAAGAGGATTTCAACTACACAATA 1121 CTATCATTGTCAGGACTATGACCTCAGGCACTCTAAACATATGTTTTGTTTGGTCAGCACAGCGTTTCAAAAAGTGAAGC 1201 CACTTTATAAATATTTGGAGATTTTGCAGGAAAATCTGGATCCCCAGGTAAGGATAGCAGATGGTTTTCAGTTATCTCCA 1281 GTCCACGTTCACAAAATGTGAAGGTGTGGAGACACTTACAAAGCTGCCTCACTTCTCACTGTAAACATTAGCTCTTTCCA 1361 CTGCCTACCTGGACCCCAGTCTAGGAATTAAATCTGCACCTAACCAAGGTCCCTTGTAAGAAATGTCCATTCAAGCAGTC 1441 ATTCTCTGGGTATATAATATGATTTTGACTACCTTATCTGGTGTTAAGATTTGAAGTTGGCCTTTTATTGGACTAAAGGG 1521 GAACTCCTTTAAGGGTCTCAGTTAGCCCAAGTTTCTTTTGCTTATATGTTAATAGTTTTACCCTCTGCATTGGAGAGAGG 1601 AGTGCTTTACTCCAAGAAGCTTTCCTCATGGTTACCGTTCTCTCCATCATGCCAGCCTTCTCAACCTTTGCAGAAATTAC 1681 TAGAGAGGATTTGAATGTGGGACACAAAGGTCCCATTTGCAGTTAGAAAATTTGTGTCCACAAGGACAAGAACAAAGTAT 1761 GAGCTTTAAAACTCCATAGGAAACTTGTTAATCAACAAAGAAGTGTTAATGCTGCAAGTAATCTCTTTTTTAAAACTTTT 1841 TGAAGCTACTTATTTTCAGCCAAATAGGAATATTAGAGAGGGACTGGTAGTGAGAATATCAGCTCTGTTTGGATGGTGGA 1921 AGGTCTCATTTTATTGAGATTTTTAAGATACATGCAAAGGTTTGGAAATAGAACCTCTAGGCACCCTCCTCAGTGTGGGT 2001 GGGCTGAGAGTTAAAGACAGTGTGGCTGCAGTAGCATAGAGGCGCCTAGAAATTCCACTTGCACCGTAGGGCATGCTGAT 2081 ACCATCCCAATAGCTGTTGCCCATTGACCTCTAGTGGTGAGTTTCTAGAATACTGGTCCATTCATGAGATATTCAAGATT 2161 CAAGAGTATTCTCACTTCTGGGTTATCAGCATAAACTGGAATGTAGTGTCAGAGGATACTGTGGCTTGTTTTGTTTATGT 2241 TTTTTTTTCTTATTCAAGAAAAAAGACCAAGGAATAACATTCTGTAGTTCCTAAAAATACTGACTTTTTTCACTACTATA 2321 CATAAAGGGAAAGTTTTATTCTTTTATGGAACACTTCAGCTGTACTCATGTATTAAAATAGGAATGTGAATGCTATATAC 2401 TCTTTTTATATCAAAAGTCTCAAGCACTTATTTTTATTCTATGCATTGTTTGTCTTTTACATAAATAAAATGTTTATTAG 2481 ATTGAATAAAGCAAAATACTCAGGTGAGCATCCTGCCTCCTGTTCCCATTCCTAGTAGCTAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 7048.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000359013.4 | 3UTR | UAAACAUUAGCUCUUUCCACUGCCUACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
109 hsa-miR-449b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT006349 | SIRT1 | sirtuin 1 | 2 | 1 | ||||||||
MIRT006350 | CCNE2 | cyclin E2 | 4 | 3 | ||||||||
MIRT006351 | MET | MET proto-oncogene, receptor tyrosine kinase | 2 | 1 | ||||||||
MIRT006352 | GMNN | geminin, DNA replication inhibitor | 2 | 1 | ||||||||
MIRT006353 | HDAC1 | histone deacetylase 1 | 2 | 1 | ||||||||
MIRT016137 | CDK4 | cyclin dependent kinase 4 | 1 | 1 | ||||||||
MIRT016138 | CDC25A | cell division cycle 25A | 2 | 1 | ||||||||
MIRT016139 | CDK6 | cyclin dependent kinase 6 | 4 | 3 | ||||||||
MIRT057740 | ZDHHC16 | zinc finger DHHC-type containing 16 | 2 | 2 | ||||||||
MIRT078636 | FAM104A | family with sequence similarity 104 member A | 2 | 2 | ||||||||
MIRT100407 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 2 | 2 | ||||||||
MIRT115552 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT130146 | TXNIP | thioredoxin interacting protein | 2 | 4 | ||||||||
MIRT142254 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT143724 | CCL22 | C-C motif chemokine ligand 22 | 2 | 2 | ||||||||
MIRT168101 | E2F3 | E2F transcription factor 3 | 2 | 2 | ||||||||
MIRT169809 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 4 | ||||||||
MIRT183694 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT198922 | SMAD4 | SMAD family member 4 | 2 | 2 | ||||||||
MIRT202950 | TSN | translin | 2 | 4 | ||||||||
MIRT221565 | CBX3 | chromobox 3 | 2 | 2 | ||||||||
MIRT253418 | EVI5L | ecotropic viral integration site 5 like | 2 | 2 | ||||||||
MIRT294759 | ZNF551 | zinc finger protein 551 | 2 | 4 | ||||||||
MIRT307053 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT331273 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 6 | ||||||||
MIRT372293 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT374317 | MBD6 | methyl-CpG binding domain protein 6 | 2 | 2 | ||||||||
MIRT445817 | DNAAF3 | dynein axonemal assembly factor 3 | 2 | 2 | ||||||||
MIRT447158 | MFSD8 | major facilitator superfamily domain containing 8 | 2 | 2 | ||||||||
MIRT447823 | CTIF | cap binding complex dependent translation initiation factor | 2 | 2 | ||||||||
MIRT448798 | GMFB | glia maturation factor beta | 2 | 2 | ||||||||
MIRT451580 | HIRIP3 | HIRA interacting protein 3 | 2 | 2 | ||||||||
MIRT452679 | GPR156 | G protein-coupled receptor 156 | 2 | 2 | ||||||||
MIRT453158 | CNOT4 | CCR4-NOT transcription complex subunit 4 | 2 | 6 | ||||||||
MIRT453634 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT455384 | PLA2G2D | phospholipase A2 group IID | 2 | 2 | ||||||||
MIRT456958 | SPAM1 | sperm adhesion molecule 1 | 2 | 2 | ||||||||
MIRT462739 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT464321 | UST | uronyl 2-sulfotransferase | 2 | 2 | ||||||||
MIRT465641 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | 2 | 10 | ||||||||
MIRT466748 | SYNGR2 | synaptogyrin 2 | 2 | 2 | ||||||||
MIRT468345 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT469324 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | 2 | 2 | ||||||||
MIRT474361 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT475316 | IFNLR1 | interferon lambda receptor 1 | 2 | 2 | ||||||||
MIRT477759 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT477824 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | 2 | 2 | ||||||||
MIRT478265 | DDX19B | DEAD-box helicase 19B | 2 | 2 | ||||||||
MIRT481042 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 2 | ||||||||
MIRT481289 | ATXN1L | ataxin 1 like | 2 | 2 | ||||||||
MIRT482730 | COPZ1 | coatomer protein complex subunit zeta 1 | 2 | 2 | ||||||||
MIRT488780 | CYTH3 | cytohesin 3 | 2 | 2 | ||||||||
MIRT489578 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT489659 | SHMT1 | serine hydroxymethyltransferase 1 | 2 | 4 | ||||||||
MIRT490527 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT492949 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT493154 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT493845 | FOXN3 | forkhead box N3 | 2 | 4 | ||||||||
MIRT494743 | ARHGAP1 | Rho GTPase activating protein 1 | 2 | 6 | ||||||||
MIRT496491 | MAST3 | microtubule associated serine/threonine kinase 3 | 2 | 2 | ||||||||
MIRT503312 | FICD | FIC domain containing | 2 | 4 | ||||||||
MIRT503507 | ZNF623 | zinc finger protein 623 | 2 | 2 | ||||||||
MIRT504182 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT505010 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT505352 | TMEM167A | transmembrane protein 167A | 2 | 2 | ||||||||
MIRT505645 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT505710 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT505777 | SATB2 | SATB homeobox 2 | 2 | 6 | ||||||||
MIRT506208 | PHF19 | PHD finger protein 19 | 2 | 2 | ||||||||
MIRT506251 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT507786 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT508005 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT508857 | ZRSR1 | zinc finger CCCH-type, RNA binding motif and serine/arginine rich 1 | 2 | 4 | ||||||||
MIRT510546 | XBP1P1 | X-box binding protein 1 pseudogene 1 | 2 | 4 | ||||||||
MIRT511892 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT512907 | UBL4A | ubiquitin like 4A | 2 | 2 | ||||||||
MIRT513600 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT521241 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT521321 | RRAGD | Ras related GTP binding D | 2 | 4 | ||||||||
MIRT525281 | C18orf32 | chromosome 18 open reading frame 32 | 2 | 2 | ||||||||
MIRT528650 | RWDD2A | RWD domain containing 2A | 2 | 4 | ||||||||
MIRT535101 | PODXL | podocalyxin like | 2 | 2 | ||||||||
MIRT547752 | KBTBD6 | kelch repeat and BTB domain containing 6 | 2 | 4 | ||||||||
MIRT547865 | HSPA13 | heat shock protein family A (Hsp70) member 13 | 2 | 2 | ||||||||
MIRT549170 | BMP3 | bone morphogenetic protein 3 | 2 | 2 | ||||||||
MIRT550115 | SLC35G2 | solute carrier family 35 member G2 | 2 | 2 | ||||||||
MIRT556097 | MOAP1 | modulator of apoptosis 1 | 2 | 2 | ||||||||
MIRT557172 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT557422 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT557931 | FAM73A | mitoguardin 1 | 2 | 2 | ||||||||
MIRT568804 | VPS37D | VPS37D, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT571326 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT572598 | PAPLN | papilin, proteoglycan like sulfated glycoprotein | 2 | 2 | ||||||||
MIRT573437 | APOPT1 | apoptogenic 1, mitochondrial | 2 | 2 | ||||||||
MIRT574092 | VASN | vasorin | 2 | 2 | ||||||||
MIRT608688 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT608800 | ITGA11 | integrin subunit alpha 11 | 2 | 4 | ||||||||
MIRT610332 | SSX5 | SSX family member 5 | 2 | 2 | ||||||||
MIRT613158 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT625407 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | 2 | 2 | ||||||||
MIRT636603 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT638573 | IER5 | immediate early response 5 | 2 | 2 | ||||||||
MIRT639686 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT677979 | ITGB3 | integrin subunit beta 3 | 2 | 2 | ||||||||
MIRT685217 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT702570 | JARID2 | jumonji and AT-rich interaction domain containing 2 | 2 | 2 | ||||||||
MIRT706259 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT734675 | HMGB1 | high mobility group box 1 | 3 | 0 | ||||||||
MIRT736369 | HSPA1A | heat shock protein family A (Hsp70) member 1A | 1 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|